178 related articles for article (PubMed ID: 31821545)
21. Variations in gastric cancer care: a trend beyond racial disparities.
Al-Refaie WB; Gay G; Virnig BA; Tseng JF; Stewart A; Vickers SM; Tuttle TM; Feig BW
Cancer; 2010 Jan; 116(2):465-75. PubMed ID: 19950130
[TBL] [Abstract][Full Text] [Related]
22. Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.
Fitzgerald TL; Efird JT; Bellamy N; Russo SM; Jindal C; Mosquera C; Holliday EG; Biswas T
Cancer; 2017 Aug; 123(15):2909-2917. PubMed ID: 28386965
[TBL] [Abstract][Full Text] [Related]
23. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma.
Pardo F; Osorio J; Miranda C; Castro S; Miró M; Luna A; Garsot E; Momblán D; Galofré G; Rodríguez-Santiago J; Pera M;
Clin Transl Oncol; 2020 Aug; 22(8):1335-1344. PubMed ID: 31865605
[TBL] [Abstract][Full Text] [Related]
24. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
25. Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.
Lowenfeld L; Datta J; Lewis RS; McMillan MT; Mamtani R; Damjanov N; Chandrasekhara V; Karakousis GC; Drebin JA; Fraker DL; Roses RE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S863-72. PubMed ID: 26100818
[TBL] [Abstract][Full Text] [Related]
26. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
[TBL] [Abstract][Full Text] [Related]
27. Adherence to national guidelines for gastric cancer in the Netherlands: a retrospective population-based audit.
Ho VK; Damhuis RA; Hartgrink HH
Int J Cancer; 2013 Mar; 132(5):1156-61. PubMed ID: 22777695
[TBL] [Abstract][Full Text] [Related]
28. Adherence with operative standards in the treatment of gastric cancer in the United States.
Zhao B; Blair SL; Katz MHG; Lowy AM; Kelly KJ
Gastric Cancer; 2020 May; 23(3):550-560. PubMed ID: 31745679
[TBL] [Abstract][Full Text] [Related]
29. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.
Gholami S; Janson L; Worhunsky DJ; Tran TB; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Schmidt C; Weber SM; Bloomston M; Cho CS; Levine EA; Fields RC; Pawlik TM; Maithel SK; Efron B; Norton JA; Poultsides GA
J Am Coll Surg; 2015 Aug; 221(2):291-9. PubMed ID: 26206635
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
31. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
[TBL] [Abstract][Full Text] [Related]
32. Do hospital attributes predict guideline-recommended gastric cancer care in the United States?
Dudeja V; Gay G; Habermann EB; Tuttle TM; Tseng JF; Feig BW; Al-Refaie WB
Ann Surg Oncol; 2012 Feb; 19(2):365-72. PubMed ID: 21837530
[TBL] [Abstract][Full Text] [Related]
33. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
34. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant therapy for gastric cancer.
House MG; Brennan MF
Adv Surg; 2008; 42():151-68. PubMed ID: 18953815
[TBL] [Abstract][Full Text] [Related]
36. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative.
Jin LX; Sanford DE; Squires MH; Moses LE; Yan Y; Poultsides GA; Votanopoulos KI; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine EA; Winslow E; Saunders N; Spolverato G; Colditz GA; Maithel SK; Fields RC
Ann Surg Oncol; 2016 Aug; 23(8):2398-408. PubMed ID: 27006126
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
39. Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
Lane WO; Nussbaum DP; Sun Z; Blazer DG
J Surg Oncol; 2018 Jun; 117(8):1708-1715. PubMed ID: 29799615
[TBL] [Abstract][Full Text] [Related]
40. Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections.
Shulman LN; Browner AE; Palis BE; Mallin K; Kakade S; Carp N; McCabe R; Winchester D; Wong SL; McKellar DP
Ann Surg Oncol; 2019 Jun; 26(6):1613-1621. PubMed ID: 30927195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
